Malaysian Genomics Resource (0155) — Cash Flow-to-Debt Ratio
Malaysian Genomics Resource (0155) has a Cash Flow-to-Debt Ratio of 0.33x as of June 2026, meaning its operating cash flow of RM1.01 Million could theoretically repay 0% of its total liabilities (RM3.09 Million) in one year. See financial agility of Malaysian Genomics Resource to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Malaysian Genomics Resource Cash Flow-to-Debt Ratio (2015–2026)
Historical debt coverage capacity for Malaysian Genomics Resource across 12 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Malaysian Genomics Resource.
Annual Cash Flow-to-Debt Ratio for Malaysian Genomics Resource (2015–2026)
Year-by-year debt coverage analysis for Malaysian Genomics Resource. Check Malaysian Genomics Resource (0155) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (MYR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2026 | 0.28x | RM1.10 Million | RM3.92 Million | ▲ +258.7% |
| 2025 | -0.18x | RM-744.97K | RM4.20 Million | ▲ +97.6% |
| 2024 | -7.44x | RM-24.97 Million | RM3.36 Million | ▼ -37.7% |
| 2023 | -5.40x | RM-22.07 Million | RM4.08 Million | ▼ -46069.1% |
| 2022 | 0.01x | RM56.92K | RM4.84 Million | ▲ +102.2% |
| 2021 | -0.54x | RM-2.64 Million | RM4.85 Million | ▼ -103.9% |
| 2020 | 14.09x | RM11.67 Million | RM827.98K | ▲ +43287.4% |
| 2019 | -0.03x | RM-687.64K | RM21.07 Million | ▲ +89.2% |
| 2018 | -0.30x | RM-6.34 Million | RM21.07 Million | ▼ -210.5% |
| 2017 | 0.27x | RM3.67 Million | RM13.49 Million | ▼ -84.7% |
| 2016 | 1.77x | RM3.68 Million | RM2.08 Million | ▲ +1722.3% |
| 2015 | 0.10x | RM395.83K | RM4.07 Million | — |